The recent recall of Nara Organics Whole Milk Organic Powdered Infant Formula has raised serious concerns following an outbreak of infant botulism. The Food and Drug Administration (FDA) issued the recall after reports of multiple infants falling ill, prompting immediate action to safeguard public health.
:max_bytes(150000):strip_icc():format(jpeg)/Nara-Organics-Whole-Milk-Organic-Powdered-Infant-Formula-061826-1-20c933e986c74093bd3fb988c0d8c3c2.jpg)
The alarming situation came to light on 17 June 2026 when the FDA announced that Nara Organics’ formula was linked to several hospitalisations caused by this rare but potentially life-threatening illness. Infant botulism has been recognised as a significant health risk, especially for infants under the age of one, as it can stem from ingestion of spores belonging to the bacteria Clostridium botulinum. Symptoms of this condition may include difficulty in feeding, constipation, reduced facial expressions, and general weakness.
So far, there are three confirmed or suspected cases associated with the formula, reported in California, Pennsylvania, and Washington. The last reported case occurred on 31 May 2026. In response to the outbreak, health authorities in these states have collected sample products for laboratory testing to better understand the extent of the issue and to confirm any possible link to the clinical cases.
Nara Organics Whole Milk Organic Powdered Infant Formula was available for purchase nationwide, sold at Target stores, as well as through Target.com and Nara.com’s online platform. The product was on shelves from July 2025 until its recall in June 2026. As the FDA’s investigation continues, they have urged parents and caregivers to cease the use of this specific formula immediately.
For those who have purchased the recalled product, the FDA advises that it should be clearly marked with a “DO NOT USE” label and stored safely away from any other infant feeding items. Furthermore, the agency recommends thoroughly cleaning any surfaces or utensils that may have come into contact with the formula. This can be done using hot, soapy water or in a dishwasher to eliminate any potential contamination risks.
Parents who suspect their baby may be exhibiting symptoms of infant botulism are encouraged to seek medical advice promptly. Early intervention is crucial, and healthcare providers can offer guidance on how best to address the health concerns. Additionally, parents can report any complaints or adverse reactions directly to the FDA’s Industry and Consumer Assistance portal, which helps to monitor and respond to health and safety issues effectively.
The situation remains fluid as investigations progress. The FDA has assured the public that it will provide updates as more information becomes available. Ensuring the safety of infant food products is paramount, and the recall highlights the ongoing vigilance necessary in monitoring food-related health risks.
In light of these developments, parents are reminded to stay informed about recalls and safety notices relating to infant products. Engaging with reliable sources of information, including the FDA’s official communications, can significantly aid in preventing potential health risks from contaminated products.
As the investigation unfolds, the FDA continues to collaborate with state health authorities to understand the full scope of the outbreak and to prevent further cases of infant botulism linked to Nara Organics. Parents are urged to remain attentive to the well-being of their infants and to take any necessary precautions to safeguard their health while this situation is under scrutiny.